respiratory tract

临床试验

计划入组 325 人 · 首次发布于 2016 年 10 月 14 日

招募中

NCT00471250

Collection of Lung Fluid and Tissue Samples for Research

计划入组 550 人 · 首次发布于 2007 年 5 月 9 日

已完成

NCT01272635

Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.

计划入组 607 人 · 首次发布于 2011 年 1 月 10 日

药物

查看全部 202 →

Small Molecule

Approved

Dexbrompheniramine(Ala-hist Ir, Ala-hist PE, Dologen, Dologesic Reformulated Jun 2016)

生产企业：Schering corp sub schering plough corp

相关疾病：Allergic Rhinitis (AR), Upper respiratory tract hypersensitivity reaction, site unspecified

C₁₆H₁₉BrN₂

Small Molecule

Approved

Oxolamine

相关疾病：Cough, Laryngitis，另有 5 项

C₁₄H₁₉N₃O

Small Molecule

Experimental

Terpineol

相关疾病：Common Cold, Laryngitis，另有 3 项

C₁₀H₁₈O

机构

查看全部 103 →

TRACT Therapeutics, Inc.

United States

Pneuma Respiratory, Inc.

United States

Japanese Respiratory Society

Japan

资讯

查看全部 3195 →

去年

Yale Study Shows Nasal Vaccine Boosters Effective Without Adjuvants for Respiratory Disease Protection

去年

Intranasal COVID-19 Vaccines Show Superior Mucosal Immunity and Long-Term Protection in Preclinical Studies

去年

临床试验

Microbiota Upper Respiratory Tract

Collection of Lung Fluid and Tissue Samples for Research

Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.

药物

Dexbrompheniramine(Ala-hist Ir, Ala-hist PE, Dologen, Dologesic Reformulated Jun 2016)

Oxolamine

Terpineol

机构

TRACT Therapeutics, Inc.

Pneuma Respiratory, Inc.

Japanese Respiratory Society

资讯

Yale Study Shows Nasal Vaccine Boosters Effective Without Adjuvants for Respiratory Disease Protection

Intranasal COVID-19 Vaccines Show Superior Mucosal Immunity and Long-Term Protection in Preclinical Studies

Ethris Reports Successful Phase 1 Results for Novel Nasal mRNA Therapy ETH47 in Asthma Treatment